AMH CUT-OFF VALUES FOR PREDICTING OVARIAN RESPONSE IN IVF. Nguyễn Xuân Hợi, MD, PhD Hoàng Văn Hùng MsC, MD

Similar documents
lbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour

Biomarkers for Prediction of Pregnancy Outcome in Fertility Patients. Scott Nelson Muirhead Chair in Obstetrics & Gynaecology

COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL

Questions. Ultrasound markers of ovarian reserve Modena April 18-19, Your choice is.. Impact study: stop OR tests or Soft catheters??

Prognosticating ovarian reserve by the new ovarian response prediction index

NGUYEN QUOC ANH. M.D., M.Sc. Tu Du Hospital Vietnam

JMSCR Vol 06 Issue 09 Page September 2018

Individualized treatment based on ovarian reserve markers

Dr. Ernesto Bosch Instituto Valenciano de Infertilidad Valencia, Spain. Declared no potential conflict of interest

LH activity administration during the

(Predictive. value) Soheila Ansaripour Fellowship of infertility Ai Avicena Research In

Neil Goodman, MD, FACE

Personalizing ovarian stimulation for IVF

Evaluation of ovarian response prediction according to age and serum AMH levels in IVF cycles: a retrospective analysis

The emergence of Personalized Medicine protocols for IVF.

Androgen supplementation in women with low functional ovarian reserve

Evidence-based treatment of POR and POF. Ovarian Club X and CoGEN in Asia December 16-17, 2017 Hong Kong

A Tale of Three Hormones: hcg, Progesterone and AMH

Puberty and Fertility. Normal Female Puberty PUBERTY! What about girls with Galactosemia? E Puberty and Fertility Badik Spencer 1

IVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF

Infertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF

Research Article. Jayakrishnan Krishnakumar 1, Akansha Agarwal 1, Divya Nambiar 1, Shankar Radhakrishnan 2 *

INFERTILITY: DIAGNOSIS, WORKUP AND MANAGEMENT FOR THE COMMUNITY PHYSICIAN

Comparison of anti-mullerian hormone and antral follicle count for assessment of ovarian reserve

Minimising IVF related mortality and morbidity. Scott Nelson Muirhead Professor in Obstetrics & Gynaecology

L6: DuoStim: the alternative of oocytes/embryos accumulation programs Carlo Alviggi

Individualized Controlled Ovarian Stimulation: Biomarker-Guided Treatment Personalization

Reproduction. AMH Anti-Müllerian Hormone. Analyte Information

Poor & Hyper responders: what is the best approach?

What is the POSEIDON concept?

How to supplement hypo-androgenic women correctly

Anti-Mullerian hormone (AMH) as predictor of ovarian reserve

Advanced age, poor responders and the role of LH supplementation. C. Alviggi University Federico II, Naples, Italy

A multi-centre, multinational, cross-sectional, incident case control study on Factors associated with the development of

Anti-Mullerian Hormone as a Predictive Factor in Assisted Reproductive Technique of Polycystic Ovary Syndrome Patients

Infertility Clinical Guideline

ENDOCRINE CHARACTERISTICS OF ART CYCLES

(BMI)=18.0~24.9 kg/m 2 ;

Is it the seed or the soil? Arthur Leader, MD, FRCSC

Antral follicle count as a predictor of ovarian response

POSEIDON s stratification of Low prognosis patients in ART and its new proposed marker of successful outcome: The WHY, the WHAT, and the HOW

Best practices of ASRM and ESHRE

Predictive factors for ovarian response in a corifollitropin alfa/gnrh antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles

Manish Banker. Declared receipt of grants; member of a company advisory board, board of director or similar group

Anti-Müllerian hormone testing is useful for individualization of stimulation protocols in oocyte donors

Influence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser

Ontogeny of the new hypo-androgenic PCOS phenotype

Follicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation

Ovarian stimulation and inflammation, not always friends! Marc-André Sirard DVM PhD, Canadian Research Chair in Reproduction Genomics

Medicine, Al-Nahrain University

Thrombosis during assisted reproduction. Scott Nelson Muirhead Chair in Obstetrics & Gynaecology

Should we offer fertility preservation to all patients with severe endometriosis?

Raoul Orvieto. The Chaim Sheba Medical Center Tel Hashomer, Israel. Declared no potential conflict of interest

A Tale of Three Hormones: hcg, Progesterone and AMH

The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.

In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome

Evaluation of Dehydroepiandrosterone Supplementation on Diminished Ovarian Reserve: A Randomized, Double-Blinded, Placebo-Controlled Study

Association of ovarian reserve with age, BMI and serum FSH level in subfertile women

The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins

Results and Discussion

STIMULATION AND OVULATION TRIGGERING

Ovarian hyperstimulation syndrome (OHSS)

Infertility treatment

Reproductive FSH. Analyte Information

Do aromatase inhibitors have a place in IVF?

Nomogram to predict the number of oocytes retrieved in controlled ovarian stimulation

Fertility What do GP s need to know? Richard Fisher Fertility Associates

Progesterone and clinical outcomes

S. AMH in PCOS Research Insights beyond a Diagnostic Marker

The 6 th Scientific Meeting of the Asia Pacific Menopause Federation

LOW RESPONDERS. Poor Ovarian Response, Por

Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial

Infertility: A Generalist s Perspective

Thesis. Mahmoud Sedki Yassin (MsC) Cairo University. Under supervision of

Use of in vitro maturation for fertility preservation

The Significance of Low Anti-Müllerian Hormone Levels in Young Women Undergoing in Vitro Fertilization

Assessment of ovarian reserve: Anti Mullerian hormone versus follicle stimulating hormone

2017 United HealthCare Services, Inc.

Treatment of Poor Responders

Impact of Ovarian Endometrioma Per Se and Surgery on Ovarian Reserve and Pregnancy Rate in in Vitro Fertilization Cycles

Potentials for iatrogenic ovarian hyporresponse following

WHY INVESTIGATE FOR INFERTILITY

Luteal phase rescue after GnRHa triggering Progesterone and Estradiol

Medicine, University of Glasgow, Glasgow, United Kingdom; and c The Fertility Clinic, Odense University Hospital, Odense, Denmark

Prijevremena insuficijencija jajnika (dijagnoza, terapija, socijalno zamrzavanje) / Premature ovarian failure (diagnosis, therapy, social freezing)

(1.,, ) (2.,,, )

N. Shirazian, MD. Endocrinologist

Fertility assessment and assisted conception

Brief Report. What s Known. Keywords Melatonin Ovarian reserve Assisted reproductive techniques Embryo Oocytes. What s New.

Prognostic factors of ovarian response and IVF outcome in patients with deep infiltrating endometriosis Claire GAUCHE-CAZALIS, Chadi YAZBECK

LUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi

ORIGINAL ARTICLE Reproductive endocrinology. A. Nyboe Andersen 1, H. Witjes 2, K. Gordon 3, and B. Mannaerts 4, * on behalf of the Xpect investigators

Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization

Approved January Waltham Forest CCG Fertility policy

Lan Wang, Yiqing Zhao, Xiyuan Dong, Kai Huang, Rui Wang, Licheng Ji, Ya Wang, Hanwang Zhang

Recent Developments in Infertility Treatment

Optimizing Fertility and Wellness After Cancer. Kat Lin, MD, MSCE

International Journal of Pharma and Bio Sciences ENDOCRINE MARKERS AND DECLINE IN REPRODUCTIVE POTENTIAL OF WOMEN ABSTRACT

Transcription:

AMH CUT-OFF VALUES FOR PREDICTING OVARIAN RESPONSE IN IVF Nguyễn Xuân Hợi, MD, PhD Hoàng Văn Hùng MsC, MD

INTRODUCTION Ovarian stimulation is an important process in IVF treatment, aiming at obtain a number of quality oocytes. To avoid OHSS and poor response. Reproductive endocrinologists check following biochemical tests to predict the efficiency of stimulation: Woman s Age FSH E2 day 3 AFC

INTRODUCTION Recently, AMH has been researched to evaluate the relationship between number of obtained oocytes and the rest of process. However, studies have shown that value of AMH still varies for predicting ovarian response.

OBJECTIVES 1. To determine AMH cut-off values for predicting ovarian response in IVF 2. To compare AMH values with FSH, AFC and E2 for predicting ovarian response.

BACKGROUND 1. Ovarian stimulation in IVF treatment Definition: ovarian stimulation in IVF is a method of using hormones to stimulate number of follicles in order to obtain higher number of oocytes, getting higher pregnancy rate. Antagonist protocol: FSH used in the beginning of menstrual period. Then, Antagonist was used in day 6 or when diameter of follicles over 14 mm, to avoid peak of LH.

BACKGROUND 2. Ovarian responsiveness Normal responder: obtained oocytes ranged from 5-15. High responder: Obtained more than 15 oocytes, no different in pregnancy rate, over 18 oocytes increase the risk of OHSS Poor responder: obtained oocytes under 4, lower pregnancy rate, drop-out due to non-response, increase cost of treatment.

BACKGROUND 3. Ovarian reserve Ovarian reserve is a term that is used to determine the capacity of the ovary to provide egg cells that are capable of fertilization resulting in a healthy and successful pregnancy. reduce with female s age Reduce ovarian reserve leads to poor response

BACKGROUND 4. Factors that determine ovarian reserve Wife's age Level of FSH AFC LEvel of E2 Level of AMH

AGE Age PR (%) < 30 years 13.6 30 34 years 13.5 35 39 years 12.6 40 years 5.0 Age related significantly to low pregnancy rate (P < 0.05) in woman > 40 years old (Wainer R et al, 2004) PR 24.9% (66/265) (< 30 yrs ) VS. 12.9% (11/85) ( 30 yrs) per cycle (Zadehmodarres S et al, 2009) Implantation rate decresed by age (ASRM Practice Committee. Aging and Infertility in women. Fertil Steril 2006)

FSH Evidence Level 2b Understanding Biomarkers FSH is not very accurate to assess ovarian response or pregnancy risk in ART What is known? Cut-off point of 11.4 IU/L*: Low number of false positives High specificity (83%-100%) to predict 4 retrieved oocytes Low sensitivity (10%-30%) to predict DOR and failure to achieve pregnancy in ART High number of false negatives Normal FSH values DOR or failure to pregnancy Cannot Identify High Responders Esteves, 10 *Standardized assays by WHO IRP 78/549 Esposito et al. Hum Reprod 2002;17:118; ASRM Practice Committee, Fertil Steril 2012;98:147.

AFC Understanding Biomarkers What is known? Direct Biomarker of Functional Ovarian Reserve: Sum of antral follicles in both ovaries on TVUS at early follicular phase (D2-D4): 2-10 mm (mean diameter) Greatest 2D-plane Decrease in the number of detectable (TVUS) antral follicles with aging Reflect the number of antral follicles in the ovaries at a given time that can be stimulated by exogenous gonadotropins Esteves, 11 Broekmans et al. Fertil Steril, 2010; 94(3):1044-51; Scheffer et al. Hum Reprod 2003;18:700

AMH Understanding Biomarkers What is known? Direct Biomarker of Ovarian Reserve: Dimeric glycoprotein; ~140KDa Product of GCs of early follicles Pre-antral and small antral ( 4-8mm) Reflect both the number of small growing follicles and the primordial pool at gonadotropinindependent folliculogenesis Esteves, 12 La Marca et, Hum Reprod 2009;24:2264; Fleming et al, Fertil Steril 2012;98:1097.

AMH Understanding Biomarkers AMH Serum Levels: Peak at age 25 and decrease with aging Early marker of diminished ovarian reserve Basic Concepts Non-growing follicles (NGF) recruited per month Esteves, 13 Kelsey et al. Mol Hum Reprod 2012;18:79

AMH Evidence Level 2a Understanding Biomarkers AMH is accurate to assess ovarian response What is known? Cut-off point of 3.5 ng/ml* (Nardo et al, Fertil Steril 2009;92:1586) High sensitivity (88%), specificity (70%) and accuracy (0.81) to predict excessive response 1 Cut-off point of 1.4 ng/ml* (Kwee et al, Fertil Steril 2008;90:737) High sensitivity (76%) and specificity (86%) to predict DOR 2 Caution to apply AMH cut-off points! Make sure the assay you rely on is the same used in the reference population Esteves, 14 *DSL assay; 1 >20 oocytes retrieved; 2 5 oocytes retrieved; Conversion: ng/ml to pmol/l = value in ng/ml X7.14

BACKGROUND 5. Factors affect AMH Age Race Alcohol users, smoking users Diabetes PCOS Using contraceptive methods Administration of chemotherapy or radiation Surgical removal of one or both ovaries

MATERIALS AND METHODOLOGY 1. Materials IVF Patients from October, 2014 to June, 2015 at National Center for ART. Study design Prospective study. Sample size Sample size: 600 patients. 2 SN (1 SN) TP FN Z 2 W N TP P FN

RESULTS AND DISCUSSION 1. Personal characteristics Age Age group n % 18-24 31 5,2 25-29 179 29,8 30-34 252 42,0 35-39 86 14,3 40-45 52 8,7 Mean (min max) 31,7 ± 5,2 (18 45)

RESULTS AND DISCUSSION Types of infertility n Tỷ lệ % Primary 328 54,7 Secondary 272 45,3 TOtal 600 100,0

RESULTS AND DISCUSSION Length of infertility n % < 5 313 52,2 5-10 years 254 42,3 > 10 years 33 5,5 Total 600 100,0 Mean 5,0 ± 3,2 (1,5 26,0)

RESULTS AND DISCUSSION Cause of infertility n % Female 232 38,6 Male 59 9,8 Both 44 7,4 Unknown 265 44,2 Total 600 100,0

Mean of AMH RESULTS AND DISCUSSION 2. To determine AMH's predictive value for ovarian response n % Mean Min Max p Poor 28 4,7 1,04 ± 0,52 0,22 3,5 Normal 374 62,3 3,52 ± 2,17 0,4 22,0 <0,001 High 198 33 7,02 ± 3,73 2,0 23,6 Total 600 100% 4,57 ± 3,25 0,22 23,6

RESULTS AND DISCUSSION AMH s predictive value of ovarian response Predicted poor response (< 4 oocytes) cutoff Sen Spec AMH ng/ml 1,13 88% 71% 1,25 85% 75% 1,36 84% 85% 1,47 81% 89% 1,52 80% 93% 1,58 79% 92% 1,63 73% 92% 1,69 74% 92% Vương Thị Ngọc Lan, cutoff: 1,25 ng/ml, Sen 87%; Spec 85% Ebner, Cutoff 1,66 ng/ml, Sen 69%; Spec 86%.

Sensitivity RESULTS AND DISCUSSION ROC for poor response 1- Specificity AUC of AMH: 91%, p < 0,01. Vương Thị Ngọc Lan, AUC: 92%, p < 0,01. Relationship between level of AMH and number of oocytes r equation p Poor response 0,512 Number of oocyte = 0,534xAMH+1,904 <0,01

RESULTS AND DISCUSSION AMH s predictive value to high response Predicted high response (>15 oocytes) Value Sensitivity Specificity AMH ng/ml 3,62 78% 54% 3,87 73% 58% 3,95 73% 59% 4,04 73% 61% 4,12 72% 61% 4,21 71% 61% 4,25 69% 62% Vương Thị Ngọc Lan, cutoff: 3,97 ng/ml, Sen 82%; Spec 81%. Ebner, Cutoff: 4,52 ng/ml, Sen 67%; Spec 78%.

Sensitivity RESULTS AND DISCUSSION ROC of AMH with high response 1- Specificity AUC of AMH in high response: 71%, p < 0,01. Relationship between level of AMH and number of oocytes r Equation p high response 0,338 number of oocyte = 0,382xAMH+17,336 <0,01

RESULTS AND DISCUSSION 3. Comparision of predictive value of AMH to AFC,FSH, E2 Mean of AFC in groups of response response n Mean Min Max p Poor 28 5,29 ± 3,92 3 7 Normal 374 11,91 ± 5,86 1 30 High 198 14,25 ± 5,65 1 30 < 0,001 Total 600 12,71 ± 6,23 1 30

RESULTS AND DISCUSSION AFC s predictive value to poor response AFC Predictive value for poor response (<4 oocytes) cutoff Sen Spec 3,5 97% 35% 4,5 94% 60% 5,5 91% 78% 6,5 87% 84% 7,5 81% 89% 8,5 74% 89% 9,5 68% 92% 10,5 60% 92% 11,5 54% 92% Vương Thị Ngọc Lan, cutoff: 5 oocytes, Sen 78,7%, Spec 85,9%.

RESULTS AND DISCUSSION ROC of AFC to poor response AUC of AFC in poor response: 88,5%, p < 0,01. Vương Thị Ngọc Lan, AUC: 88%, p <0,01. Relationship between AFC and number of oocytes r equation p Poor response 0,492 No of oocytes = 0,90xAFC+1,701 <0,05

RESULTS AND DISCUSSION Mean of FSH in response groups Response n Mean Min Max p Poor 28 8,76 ± 3,39 3,00 15,00 Normal 374 6,39 ± 1,96 0,30 15,00 <0,001 High 198 5,60 ± 1,66 0,09 14,55 Total 600 6,21 ± 2,03 0,09 15,00

RESULTS AND DISCUSSION FSH's predictive value to poor response FSH (IU/L) Predictive value to poor response (< 4 oocytes) cutoff Sen Spec 6,79 67,8% 70,2% 6,80 67,8% 71,3% 6,81 67,8% 71,5% 6,82 67,8% 71,6% 6,83 67,8% 71,9% 6,85 64,2% 72,0% 6,87 64,2% 72,2% 6,88 64,2% 72,5% 6,89 60,7% 72,5% Vương Thị Ngọc Lan, Cutoff: 8,94; Sen 57,5%, Spec 85,4%

Sensitivity RESULTS AND DISCUSSION ROC of FSH in poor response AUC of FSH = 72,6%, p < 0,01. Vương Thị Ngọc Lan, AUC = 75%, p < 0,01. 1- Specificity Relationship between level of FSH and number of oocytes r Equation p Poor response -0,315 No. of oocyte = - 0,033xFSH+2,519 < 0,05

RESULTS AND DISCUSSION Mean of E2 in response groups response n Mean Min Max p Poor 22 34,83 ± 12,35 19,28 69,00 Normal 374 35,59 ± 18,72 4,10 174,00 High 198 37,57 ± 20,11 1,54 119,40 P>0,05 (0,464) Total 594 36,22 ± 19,00 1,54 174,00

RESULTS AND DISCUSSION Comparision of values of AMH, FSH, AFC to poor response Predict poor response (<4 oocytes) Cutoff Sen Spec AUC AMH(ng/mL) 1,52 80% 93% 91% AFC 6,5 87% 84% 88,5% FSH(IU/L) 6,83 67,8% 71,9% 72,6%

RESULTS AND DISCUSSION Predictive value of AFC in high response AFC Predict high response (>15 oocytes) Cutoff Sen Spec 7,5 88,3% 25% 8,5 85,3% 34,1% 9,5 82,8% 42,4% 10,5 78,7% 52,0% 11,5 70,7% 56,3% 12,5 61,6% 61,6% 13,5 50,0% 68,6% 14,5 44,4% 72,9%

Sensitivity RESULTS AND DISCUSSION ROC of AFC in high response 1- Specificity AUC of AFC in high response = 65%, p < 0,01. Relationship between AFC and number of oocytes in high response high response 0,167 r Equation p No. of oocytes = 0,108xAFC+19,281 <0,05

RESULTS AND DISCUSSION Predictive value of FSH in high response High response (> 15 oocytes) Cutoff Sen Spec FSH (IU/L) 6,07 56,0% 69,1% 6,09 55,8% 69,2% 6,10 53,5% 72,2% 6,12 53,2% 72,2% 6,14 53,2% 72,7% 6,15 53,0% 72,7% 6,17 52,7% 72,7% 6,18 52,0% 72,7%

Sensitivity RESULTS AND DISCUSSION ROC of FSH in high response AUC of FSH = 62,7%, p < 0,01. 1- Specificity Correlation of FSH and number of oocytes in high response High response -0,10 r equation p No. of oocyte = - 0,271xFSH+22,344 > 0,05

RESULTS AND DISCUSSION Comparision of values of AMH, FSH, AFC in high response high response (>15 oocytes) Cutoff Sen Spec AUC AMH (ng/ml) 4,04 73% 61% 71% AFC 10,5 78,7% 52,0% 65% FSH (IU/L) 6,145 53,2% 72,7% 62,7%

Biomarkers Clinical Utility in Ovarian Stimulation FSH AMH AFC Excessive Ovarian Response Diminishe d Ovarian Reserve (DOR) Avoid over-aggressive stimulation in true high responders ( Sensit.) Avoid over-conservative stimulation in false high - +++ +++ responders ( Specif.) - +++ +++ Avoid over-conservative stimulation in true DOR ( Sensit.) Avoid over-aggressive stimulation in false DOR ( Specif.) + +++ +++ +++ +++ +++ Esteves, 39

CONCLUSIONS 1. To determine AMH's predictive value to ovary's response in ovarian stimulation Cut-off of AMH in poor response: 1,52 ng/ml; Sen 80%; Spec 93%. 1,52 ng/ml: risk of poor response 7,4 times higher Cut-off of AMH in high response: 4,04 ng/ml; Sen 73%; Spec 61%. 4,04 ng/ml: risk of poor response 2,69 times higher

CONCLUSIONS 2. To compare AMH's predictive value to that of FSH, AFC and E2 in ovarian stimulation 2.1. In poor response: Predictive value: AMH (Sen: 80%, Spec: 93%) >> AFC (Sen: 87%, Spec: 84%) >> FSH (Sen: 67,8%, Spec: 71,9%). E2 day 3: no predictive value 2.2. In high response: Predictive value: AMH (Sen: 73%; Spec: 61%) >> AFC (Sen: 78,7%; Spec: 52,0%). FSH: no predictive value E2 day 3: no predictive value

Take home messages 1. AMH and AFC are currently the best biomarkers to predict ovarian response to COS. 2. Individualization of COS guided by such biomarkers is sound, and it is aimed to maximize the beneficial effects of treatment while minimizing complications and risks.